Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|July 9, 2021

Understanding Treatment Options in Melanoma

Author(s)Kristie L. Kahl

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

Advertisement

Advertisement
Skin Cancer
|
CURE Speaking Out
|
AIM at Melanoma

Related Content

Advertisement
Image of Yang

Gut Microbiome Patterns May Help Explain Fatigue and Pain During Melanoma Immunotherapy

ByQuincy Attobrah
May 15th 2026
melanoma

Understanding Superficial Spreading Melanoma: Diagnosis and Treatment Guide

ByAlex Biese
May 10th 2026
FDA

FDA Grants Fast Track to DOC1021 for Metastatic and Unresectable Melanoma

ByCURE staff
May 7th 2026
Dr. Michael E. Kasper of Baptist Health

How Multidisciplinary Teams Are Streamlining Skin Cancer Care

ByDr. Michael E. Kasper
May 6th 2026
The U.S. FDA has accepted its sNDA for Ameluz with the RhodoLED red-light lamp series in superficial basal cell carcinoma treatment: © stock.adobe.com.

FDA Accepts Filing of Ameluz for Superficial Basal Cell Carcinoma

ByCURE staff
February 12th 2026
Advertisement
Advertisement

Trending on CURE

1

Top 5 Takeaways From ASCO 2026 That Patients Should Know

2

Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status

3

Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care

4

Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions

5

A Cancer Survivor Reflects on Organ Donation

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.